Marlon Carlos
22Patents
7h-index
37Co-inventors
65Inventor score
Filing activity: Jan 12, 2006 → Dec 18, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9034911B2 | Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto | Chemistry; Metallurgy | 25 | Active |
| US8299241B2 | Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof | Chemistry; Metallurgy | 12 | Active |
| US7425630B2 | Processes for preparing pyrazolo[3,4-d]pyrimidine ethers | Human Necessities | 10 | Active |
| US10676435B2 | Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders | Chemistry; Metallurgy | 9 | Active |
| US11091435B2 | Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P1 receptor-associated disorders | Chemistry; Metallurgy | 8 | Active |
| US10597363B2 | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C | Chemistry; Metallurgy | 8 | Active |
| US10301262B2 | Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders | Chemistry; Metallurgy | 8 | Active |
| US9126946B2 | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto | Chemistry; Metallurgy | 7 | Active |
| US9353064B2 | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto | Chemistry; Metallurgy | 7 | Active |
| US10071075B2 | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto | Chemistry; Metallurgy | 4 | Active |
| US10981871B2 | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C | Chemistry; Metallurgy | 4 | Active |
| US9745270B2 | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto | Chemistry; Metallurgy | 4 | Active |
| US10981870B2 | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form | Chemistry; Metallurgy | 4 | Active |
| US10117851B2 | Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto | Chemistry; Metallurgy | 4 | Active |
| US9801856B2 | Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto | Chemistry; Metallurgy | 4 | Active |
| US11884626B2 | Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders | Chemistry; Metallurgy | 1 | Active |
| US11827600B2 | Crystalline forms of trofinetide | Chemistry; Metallurgy | 0 | Active |
| US12378198B2 | Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disorders | Chemistry; Metallurgy | 0 | Active |
| US11840515B2 | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c | Chemistry; Metallurgy | 0 | Active |
| US10583122B2 | Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto | Chemistry; Metallurgy | 0 | Active |
| US10543193B2 | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto | Chemistry; Metallurgy | 0 | Active |
| US8822727B2 | Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.